OBESITY, ABDOMINAL
Clinical trials for OBESITY, ABDOMINAL explained in plain language.
Never miss a new study
Get alerted when new OBESITY, ABDOMINAL trials appear
Sign up with your email to follow new studies for OBESITY, ABDOMINAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hormone drug shows promise for common fatty liver disease
Disease control CompletedThis study tested whether a drug called tesamorelin could help people with obesity and nonalcoholic fatty liver disease (NAFLD). It involved 51 adults and aimed to see if the treatment could reduce harmful fat and inflammation in the liver. The drug works by boosting a natural ho…
Matched conditions: OBESITY, ABDOMINAL
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Can banning soda at work shrink your waistline?
Prevention CompletedThis study tested whether a two-part workplace program could help employees improve their health. Researchers examined if banning sugary drink sales at work and offering brief personal counseling could help reduce belly fat and improve the body's response to sugar. Over 600 hospi…
Matched conditions: OBESITY, ABDOMINAL
Phase: NA • Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Mar 12, 2026 13:50 UTC